The study of blood purification and peritoneal dialysis are the highlighted topic today. There is so much to discuss and learn about it.
Recent technological progress has increased the number of techniques available for blood purification and their performance.
To discuss the latest developments and issues of blood purification and peritoneal dialysis, Hyderabad the City of Nizams, is going to witness one of the biggest joint Conference i.e. 37th Congress of the International Society of Blood Purification (ISBP) and the 22nd Annual Conference of the Peritoneal Dialysis Society of India (PDSI) at the Hyderabad International Convention Centre (HICC) on 18-21 September 2019.
International Society of Blood Purification (ISBP) focuses on development, improvement, dosing, monitoring to control extracorporeal and peritoneal treatment modalities of acute and terminal renal failure. It evaluates and compares the interpretation of long-term results of renal replacement therapies. Where Peritoneal Dialysis Society of India (PDSI) is a well-recognized and accepted modality of dialysis with comparable results with hemodialysis. Few countries follow – “PD first” protocol for their beneficiaries for obvious good reasons.
ISBP_PDSICON 2019 is going to talk about the Nephrology and extracorporeal therapies for both renal and non-renal indications, and this will be a rare opportunity for the Indian nephrologists and critical care practitioners to learn, interact and make acquaintances with world leaders who have practical experience in these therapies.
The worldwide faculty of more than 30 eminent experts along with the Indian key opinion leaders will make for a formidable scientific program. International and National faculty of PDSI along with ISBP will address the latest issues in the field of blood purification and Peritoneal Dialysis. Many more issues like Sepsis, Pharmacologic management of chronic kidney disease with therapies such as probiotics and Pathogenesis and prevention of long-term complications of survival on regular renal replacement therapy such as cardiovascular disease, hypertension, anemia & iron deficiency, Beta2M-amyloidosis, infections, renal osteodystrophy, malnutrition & sarcopenia will be addressed.
Authors who will present the abstracts, their presented work will be checked at the review stage, the program committee may change the presentation type submitted by the author to ensure the continuity of the conference program.
ISBP_PDSICON 2019 is managed by CIMGlobal.
For more information about ISBP_PDSICON 2019 conference kindly visit – http://www.isbp-pdsicon2019.com/